X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (49) 49
index medicus (38) 38
lymphomas (33) 33
male (32) 32
middle aged (32) 32
female (31) 31
lymphoma (31) 31
hematology (29) 29
prognosis (28) 28
adult (27) 27
oncology (27) 27
rituximab (27) 27
aged (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (20) 20
chemotherapy (20) 20
analysis (19) 19
survival (19) 19
aged, 80 and over (16) 16
neoplasm staging (14) 14
treatment outcome (13) 13
therapy (12) 12
antineoplastic agents - therapeutic use (10) 10
chronic lymphocytic leukemia (10) 10
cyclophosphamide (10) 10
patients (10) 10
retrospective studies (10) 10
antimitotic agents (9) 9
antineoplastic agents (9) 9
cancer (9) 9
maintenance (9) 9
young adult (9) 9
hematology, oncology and palliative medicine (8) 8
hodgkin lymphoma (8) 8
mantle cell lymphoma (8) 8
relapse (8) 8
angiogenesis (7) 7
disease progression (7) 7
follicular lymphoma (7) 7
multicenter (7) 7
radiotherapy (7) 7
adolescent (6) 6
b-cell lymphoma (6) 6
care and treatment (6) 6
chop (6) 6
cyclophosphamide - therapeutic use (6) 6
czech republic (6) 6
databases (6) 6
elderly (6) 6
geriatrics (6) 6
lymphocytes b (6) 6
lymphoma, follicular - drug therapy (6) 6
minimal residual disease (6) 6
prednisone - therapeutic use (6) 6
remission induction (6) 6
transplantation, autologous (6) 6
trial (6) 6
vincristine - therapeutic use (6) 6
aged patients (5) 5
antibodies, monoclonal, murine-derived - administration & dosage (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
doxorubicin - therapeutic use (5) 5
elderly people (5) 5
immunochemotherapy (5) 5
incidence (5) 5
lymphoma, large b-cell, diffuse - drug therapy (5) 5
medical prognosis (5) 5
non-hodgkins-lymphoma (5) 5
open-label (5) 5
risk factors (5) 5
rituximab - therapeutic use (5) 5
stem cell transplantation (5) 5
survival rate (5) 5
term-follow-up (5) 5
transplantation (5) 5
vincristine (5) 5
cell survival (4) 4
combined modality therapy (4) 4
disease (4) 4
diseases (4) 4
elderly-patients (4) 4
etoposide - therapeutic use (4) 4
hematopoietic stem cell transplantation (4) 4
hodgkin disease - mortality (4) 4
hodgkin disease - therapy (4) 4
kaplan-meier estimate (4) 4
leukemia (4) 4
leukemia, lymphocytic, chronic, b-cell - drug therapy (4) 4
lymphocytes (4) 4
lymphoproliferative disorders (4) 4
mantle (4) 4
medical research (4) 4
medicine & public health (4) 4
medicine, experimental (4) 4
recurrence (4) 4
rituximab - administration & dosage (4) 4
salvage therapy (4) 4
stem-cell transplantation (4) 4
studies (4) 4
t cells (4) 4
usage (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 42 - 51
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 319 - 331
Journal Article
by Horwitz, Steven and O'Connor, Owen A and O'Connor, Owen and Pro, Barbara and Illidge, Tim and Fanale, Michelle and Advani, Ranjana and Bartlett, Nancy and Bartlett, Nancy L and Christensen, Jacob Haaber and Morschhauser, Franck and Domingo-Domenech, Eva and Rossi, Giuseppe and Kim, Won Seog and Feldman, Tatyana and Lennard, Anne and Belada, David and Illés, Árpád and Tobinai, Kensei and Tsukasaki, Kunihiro and Yeh, Su-Peng and Shustov, Andrei and Hüttmann, Andreas and Savage, Kerry and Savage, Kerry J and Yuen, Sam and Iyer, Swaminathan and Zinzani, Pier Luigi and Hua, Zhaowei and Little, Meredith and Rao, Shangbang and Woolery, Joseph and Manley, Thomas and Trümper, Lorenz and Aboulafia, David and Alpdogan, Onder and Ando, Kiyoshi and Arcaini, Luca and Baldini, Luca and Bellam, Naresh and Yehuda, Dina Ben and Benedetti, Fabio and Borchman, Peter and Bordessoule, Dominique and Brice, Pauline and Briones, Javier and Caballero, Dolores and Carella, Angelo Michele and Chang, Hung and Cheong, June Weon and Cho, Seok-Goo and Choi, Ilseung and Choquet, Sylvain and Colita, Andrei and Congui, Angela Giovanna and D'amore, Francesco and Dang, Nam and Davison, Kelly and de Guibert, Sophie and Brown, Peter de Nully and Delwail, Vincent and Demeter, Judit and di Raimondo, Francesco and Do, Young Rok and Domingo, Eva and Douvas, Michael and Dreyling, Martin and Ernst, Thomas and Fay, Keith and Ferrero, Silvia Fernandez and Flinn, Ian Winchester and Forero-Torres, Andres and Fox, Christopher and Friedberg, Jonathan and Fukuhara, Noriko and Garcia-Marco, Jose and Cruz, Jorge Gayoso and Codina, Jose Gomez and Gressin, Remy and Grigg, Andrew and Gurion, Ronit and Haioun, Corinne and Hajek, Roman and Hanel, Mathias and Hatake, Kiyohiko and Hensen, Robert and Horowitz, Netanel and Huttmann, Andreas and Illes, Arpad and Ishizawa, Kenichi and Islas-Ohlmayer, Miguel and Jacobsen, Eric and Janakiram, Murali and Jurczak, Wojciech and Kaminski, Mark and Kato, Koji and Kirgner, Ilya and Kuo, Ching-Yuan and Lazaroiu, Mihaela Cornelia and Du, Katell Le and ... and ECHELON 2 Study Grp and ECHELON-2 Study Group
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 229 - 240
Journal Article
Hematological Oncology, ISSN 0278-0232, 06/2017, Volume 35, Issue S2, pp. 38 - 40
Journal Article
Hematological Oncology, ISSN 0278-0232, 06/2017, Volume 35, Issue S2, pp. 184 - 185
Journal Article
Hematological Oncology, ISSN 0278-0232, 06/2019, Volume 37, Issue S2, pp. 326 - 327
Journal Article
Hematological Oncology, ISSN 0278-0232, 06/2019, Volume 37, Issue S2, pp. 478 - 479
Journal Article
Journal Article
Future Oncology, ISSN 1479-6694, 08/2016, Volume 12, Issue 15, pp. 1759 - 1768
We describe the rationale and design of the ongoing randomized, active-controlled, multicenter, Phase III study evaluating the efficacy of pixantrone and... 
DLBCL | gemcitabine | pixantrone | relapse | aggressive non-Hodgkin lymphoma | rituximab | DRUG | ADULT PATIENTS | MALIGNANT-LYMPHOMA | MULTICENTER PHASE-II | REGIMENS | TRIAL | SINGLE-AGENT | B-CELL LYMPHOMA | ONCOLOGY | CHOP
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, p. e102594
Background: Absolute lymphocyte count (ALC) and absolute monocyte count (AMC) have been documented as independent predictors of survival in patients with newly... 
TRIAL | SURVIVAL | SUBTYPE | MARKER | RITUXIMAB | MULTIDISCIPLINARY SCIENCES | PATIENTS OLDER | ABSOLUTE LYMPHOCYTE | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Age Factors | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Monocytes - pathology | Aged, 80 and over | Vincristine - administration & dosage | Female | Leukocyte Count | Retrospective Studies | Research Design - statistics & numerical data | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Factors | Biomarkers - analysis | Lymphoma, Large B-Cell, Diffuse - mortality | Lymphoma, Large B-Cell, Diffuse - diagnosis | Lymphocytes - pathology | Survival Analysis | Aged | Antimitotic agents | Care and treatment | Lymphocytes | Analysis | Aged patients | Lymphomas | Antineoplastic agents | Elderly people | Multivariate analysis | Medical diagnosis | Risk factors | Age | Statistical analysis | Cell survival | Internal medicine | Risk groups | Hematology | Dentistry | Risk analysis | Patients | Survival | Lymphoma | Medicine | Studies | Population (statistical) | Chemotherapy | Monocytes | Hospitals | Lymphocytes B | Cell number | Medical prognosis | Predictions | Elderly | Cancer | Geriatrics | B-cell lymphoma
Journal Article